메뉴 건너뛰기




Volumn 104, Issue 5 SUPPL., 2009, Pages 30C-33C

Definition, Incidence, Correlates, and Clinical Impact of "Nuisance" Bleeding in Patients Undergoing Drug-Eluting Stent Implantation

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PRASUGREL;

EID: 68649092009     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.06.012     Document Type: Article
Times cited : (6)

References (15)
  • 1
    • 0023864355 scopus 로고
    • Thrombolysis In Myocardial Infarction (TIMI) trial-phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
    • Rao A.K., Pratt C., Berke A., Jaffe A., Ockene I., Schreiber T.L., Bell W.R., Knatterud G., Robertson T.L., and Terrin M.L. Thrombolysis In Myocardial Infarction (TIMI) trial-phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 11 (1988) 1-11
    • (1988) J Am Coll Cardiol , vol.11 , pp. 1-11
    • Rao, A.K.1    Pratt, C.2    Berke, A.3    Jaffe, A.4    Ockene, I.5    Schreiber, T.L.6    Bell, W.R.7    Knatterud, G.8    Robertson, T.L.9    Terrin, M.L.10
  • 2
    • 0027240597 scopus 로고
    • An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
    • The GUSTO Investigators
    • The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329 (1993) 673-682
    • (1993) N Engl J Med , vol.329 , pp. 673-682
  • 4
    • 33846102236 scopus 로고    scopus 로고
    • Assessment of bleeding events in clinical trials-proposal of a new classification
    • Serebruany V.L., and Atar D. Assessment of bleeding events in clinical trials-proposal of a new classification. Am J Cardiol 99 (2007) 288-290
    • (2007) Am J Cardiol , vol.99 , pp. 288-290
    • Serebruany, V.L.1    Atar, D.2
  • 5
    • 63749112292 scopus 로고    scopus 로고
    • Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?
    • Usman M.H., Notaro L.A., Nagarakanti R., Brahin E., Dessain S., Gracely E., and Ezekowitz M.D. Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?. Am J Cardiol 103 (2009) 1107-1112
    • (2009) Am J Cardiol , vol.103 , pp. 1107-1112
    • Usman, M.H.1    Notaro, L.A.2    Nagarakanti, R.3    Brahin, E.4    Dessain, S.5    Gracely, E.6    Ezekowitz, M.D.7
  • 6
    • 33646732608 scopus 로고    scopus 로고
    • Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease
    • Jernberg T., Payne C.D., Winters K.J., Darstein C., Brandt J.T., Jakubowski J.A., Naganuma H., Siegbahn A., and Wallentin L. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease. Eur Heart J 27 (2006) 1166-1173
    • (2006) Eur Heart J , vol.27 , pp. 1166-1173
    • Jernberg, T.1    Payne, C.D.2    Winters, K.J.3    Darstein, C.4    Brandt, J.T.5    Jakubowski, J.A.6    Naganuma, H.7    Siegbahn, A.8    Wallentin, L.9
  • 7
    • 0141919739 scopus 로고    scopus 로고
    • Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study
    • Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators
    • Peters R.J., Mehta S.R., Fox K.A., Zhao F., Lewis B.S., Kopecky S.L., Diaz R., Commerford P.J., Valentin V., Yusuf S., and Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study. Circulation 108 (2008) 1682-1687
    • (2008) Circulation , vol.108 , pp. 1682-1687
    • Peters, R.J.1    Mehta, S.R.2    Fox, K.A.3    Zhao, F.4    Lewis, B.S.5    Kopecky, S.L.6    Diaz, R.7    Commerford, P.J.8    Valentin, V.9    Yusuf, S.10
  • 8
    • 0037145863 scopus 로고    scopus 로고
    • Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial
    • CREDO Investigators
    • Steinhubl S.R., Berger P.B., Mann III J.T., Fry E.T., DeLago A., Wilmer C., Topol E.J., and CREDO Investigators. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288 (2002) 2411-2420
    • (2002) JAMA , vol.288 , pp. 2411-2420
    • Steinhubl, S.R.1    Berger, P.B.2    Mann III, J.T.3    Fry, E.T.4    DeLago, A.5    Wilmer, C.6    Topol, E.J.7
  • 9
    • 3242770664 scopus 로고    scopus 로고
    • Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
    • MATCH investigators
    • Diener H.C., Bogousslavsky J., Brass L.M., Cimminiello C., Csiba L., Kaste M., Leys D., Matias-Guiu J., Rupprecht H.J., and MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364 (2004) 331-337
    • (2004) Lancet , vol.364 , pp. 331-337
    • Diener, H.C.1    Bogousslavsky, J.2    Brass, L.M.3    Cimminiello, C.4    Csiba, L.5    Kaste, M.6    Leys, D.7    Matias-Guiu, J.8    Rupprecht, H.J.9
  • 10
    • 33644876597 scopus 로고    scopus 로고
    • Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial
    • Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis In Myocardial Infarction (TIMI) 28 Investigators
    • Sabatine M.S., Morrow D.A., Montalescot G., Dellborg M., Leiva-Pons J.L., Keltai M., Murphy S.A., McCabe C.H., Gibson C.M., Cannon C.P., and Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis In Myocardial Infarction (TIMI) 28 Investigators. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial. Circulation 112 (2005) 3846-3854
    • (2005) Circulation , vol.112 , pp. 3846-3854
    • Sabatine, M.S.1    Morrow, D.A.2    Montalescot, G.3    Dellborg, M.4    Leiva-Pons, J.L.5    Keltai, M.6    Murphy, S.A.7    McCabe, C.H.8    Gibson, C.M.9    Cannon, C.P.10
  • 12
    • 68649127826 scopus 로고    scopus 로고
    • Torguson R, Ben-Dor I, Kaneshige K, Pichard AD, Satler LF, Kent KM, Suddath WO, Waksman R. Incidence and correlates of nuisance bleeding following anti-platelet therapy for patients with drug eluting stents. (Abstract; Submitted to European Society of Cardiology (ESC) Congress 2009).
    • Torguson R, Ben-Dor I, Kaneshige K, Pichard AD, Satler LF, Kent KM, Suddath WO, Waksman R. Incidence and correlates of nuisance bleeding following anti-platelet therapy for patients with drug eluting stents. (Abstract; Submitted to European Society of Cardiology (ESC) Congress 2009).


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.